
Health Wildcatters Launches HW Venture Center to Foster Investor-Startup Matchmaking
Fourteen investors have committed to offering office hours at the HW Venture Center in July and August.
Fourteen investors have committed to offering office hours at the HW Venture Center in July and August.
The conference will explore ethical considerations for AI in healthcare, how the healthcare industry is managing the teething challenges of AI "hallucinations", practical concerns such as efficacy and ROI, and more. Register today!
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
This week, longtime healthcare veterans Amy Abernethy and Brad Hirsch teamed up to launch Highlander Health — a Dallas-based startup focused on accelerating clinical evidence generation.
The theme of the Pitch Perfect contest at INVEST Digital Health in Dallas is pediatric mental health. Six companies will compete in the event at Pegasus Park on September 18. Register today!
The roster of speakers at INVEST Digital Health scheduled for September 18 in Dallas includes executives from health systems, healthcare entrepreneurs, and more. Register today!
MedCity's annual INVEST Digital Health conference in Dallas September 18 will delve into innovation at the intersection of AI and drug development, investment trends, consumer-focused diagnostics and validating digital health tools.
In a fireside chat at INVEST Digital Health in Dallas, Polsinelli Healthcare M&A Co-chair Jonathan Henderson and Jim Walton, President of JWalton LLC discussed the healthcare preferences of different generations and how they will impact caregiving.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
AI technologies have a role in the life sciences that goes beyond drug discovery. A panel at the MedCity News INVEST conference in Dallas discussed how new tech platforms help speed up the process of recruiting patients and running clinical trials.
Digital therapeutics have shown how therapy can be delivered effectively through a digital interface, but the bankruptcy of Pear Therapeutics raised questions about whether these technologies can be commercially successful. A panel at the MedCity News INVEST Digital Health conference discussed the promise and pitfalls of these emerging technologies.
The INVEST Digital Health conference in Dallas, a collaboration between MedCity News and the Health Wildcatters accelerator, spotlights a wide range of hot topics in digital health, a startup pitch contest focused on femtech, and networking opportunities with investors and healthcare stakeholders. Register today!
The group of 10 startups in the accelerator have ambitions to improve early detection of lung cancer, eliminate contaminated needles, improve remote monitoring and provide new ways to treat head lice, among other goals.
Clinical trial design will be one of the topics discussed at the upcoming INVEST Digital Health conference in Dallas on October 26. THREAD Clinical Trial Design Director Noah Goodson highlighted some of the milestones the sector has seen in recent years.
Taysha Gene Therapies has encouraging data from an open-label, Phase 1/2 study in the rare disease giant axonal neuropathy. It might not be enough. The FDA recommended the biotech conduct a randomized and placebo-controlled study—a challenge in any ultra-rare disease.
Astellas has purchased an equity stake in Taysha Gene Therapies in a $50 million deal that gives it an option to license the company’s two lead gene therapy candidates. The Japanese pharmaceutical giant also gains the option to buy its new partner outright depending on clinical and regulatory developments expected in the coming year.